News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Rahul Banerjee: Fascinating 3-way randomized trial of neuromuscular training
Rahul Banerjee/X
Jul 7, 2024, 14:46

Rahul Banerjee: Fascinating 3-way randomized trial of neuromuscular training

Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X:

“This is fascinating!
3-way randomized trial of neuromuscular training (by sports therapists) in patients with cancer receiving vincristine or oxaliplatin.

CIPN incidence 30-45% vs >70% in control arm

Maybe something similar with bortezomib in multiple myeloma is next?”

Rahul Banerjee: Fascinating 3-way randomized trial of neuromuscular training

Source: Rahul Banerjee/X

Bortezomib cancer Cancer research cancer treatment chemotherapy-induced peripheral neuropathy CIPN multiple myeloma neuromuscular training OncoDaily Oncology oxaliplatin Rahul Banerjee randomized trial sports therapy UW Medicine vincristine
Special Coverage
Blog
Apr 18, 2025, 14:29
Antonio Giordano: Rep. Jesse Topper visited Sbarro Health Research Organization Genetic Research Laboratory
Blog
Apr 18, 2025, 14:07
Humaid Al-Shamsi: BCI signed an MoU with the European Institute of Oncology at Abu Dhabi Global Health Week
Blog
Apr 18, 2025, 13:54
Tanja Obradovic: Novel cell therapy is entering clinical development space
Drugs
Apr 18, 2025, 13:39
Amol Akhade: First-line treatment options for NSCLC with uncommon EGFR mutations
Blog
Apr 18, 2025, 13:07
Tanja Obradovic: Even rougher times ahead for Biotech?
Blog
Apr 18, 2025, 12:54
Adam Fein: New on Drug Channels - who really controls specialty drug dispensing?
Societies
Apr 18, 2025, 12:24
Giving Week 2025: There’s still time to activate or renew your ACS CAN membership
Positive
Apr 18, 2025, 12:14
2025 ASCO Annual Meeting Merit Award and Special Merit Award recipients
Insight
Apr 18, 2025, 11:51
Applications for 2025 Home Away From Home program are now open - Foundation S
Insight
Apr 18, 2025, 11:31
New Whitepaper Explores Cardiovascular Risks of ADT in Prostate Cancer - International Cardio-Oncology Society
Blog
Apr 18, 2025, 11:18
TLC Conference Thanks its Incredible Faculty for Making Texas Lung 25 a Success
Blog
Apr 18, 2025, 11:12
Donde Quiero Estar Foundation highlights the real barriers people with cancer face in Argentina - UICC